3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:SSRX
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio:
- P/E Growth:
Frequently Asked Questions for 3SBio (NASDAQ:SSRX)
What is 3SBio's stock symbol?
3SBio trades on the NASDAQ under the ticker symbol "SSRX."
How were 3SBio's earnings last quarter?
3SBio Inc (NASDAQ:SSRX) issued its quarterly earnings data on Monday, March, 18th. The company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by $0.02. The company earned $26.30 million during the quarter, compared to the consensus estimate of $25.63 million. View 3SBio's Earnings History.
Who are some of 3SBio's key competitors?
Some companies that are related to 3SBio include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT), Allos Therapeutics (ALTH) and AMERIGROUP (AGP).
How do I buy 3SBio stock?
Shares of 3SBio can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of 3SBio stock cost?
One share of 3SBio stock can currently be purchased for approximately $14.92.
Consensus Ratings for 3SBio (NASDAQ:SSRX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for 3SBio (NASDAQ:SSRX)
(Data available from 5/25/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|3/20/2017||Goldman Sachs Group Inc||Upgrade||Neutral -> Buy||Low|
Earnings History for 3SBio (NASDAQ:SSRX)Earnings History by Quarter for 3SBio (NASDAQ:SSRX)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/18/2013||Q4 2012||$0.14||$0.12||$25.63 million||$26.30 million||View||Listen|
|11/12/2012||Q312||$0.29||$0.15||$28.18 million||$28.70 million||View||N/A|
Earnings Estimates for 3SBio (NASDAQ:SSRX)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for 3SBio (NASDAQ:SSRX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for 3SBio (NASDAQ:SSRX)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for 3SBio (NASDAQ:SSRX)
Latest Headlines for 3SBio (NASDAQ:SSRX)
3SBio (SSRX) Chart for Thursday, May, 25, 2017